- Report
- February 2024
- 170 Pages
Global
From €3978EUR$4,500USD£3,447GBP
- Report
- February 2024
- 172 Pages
Global
From €3978EUR$4,500USD£3,447GBP
- Report
- November 2023
- 171 Pages
Global
From €3978EUR$4,500USD£3,447GBP
- Report
- November 2023
- 90 Pages
France
From €3094EUR$3,500USD£2,681GBP
- Report
- November 2023
- 81 Pages
Germany
From €3094EUR$3,500USD£2,681GBP
- Report
- October 2023
- 81 Pages
Japan
From €3094EUR$3,500USD£2,681GBP
- Report
- March 2023
- 117 Pages
Global
From €3978EUR$4,500USD£3,447GBP
- Report
- December 2022
- 111 Pages
Global
From €3978EUR$4,500USD£3,447GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2652EUR$3,000USD£2,298GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €4420EUR$5,000USD£3,829GBP
- Clinical Trials
- April 2025
- 550 Pages
Global
From €4420EUR$5,000USD£3,829GBP
- Drug Pipelines
- April 2025
- 200 Pages
Global
From €2210EUR$2,500USD£1,915GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2652EUR$3,000USD£2,298GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2210EUR$2,500USD£1,915GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1768EUR$2,000USD£1,532GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €4420EUR$5,000USD£3,829GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2652EUR$3,000USD£2,298GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €1326EUR$1,500USD£1,149GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1326EUR$1,500USD£1,149GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1326EUR$1,500USD£1,149GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more